文献速递遗传性与小管间质肾病

XBP1激活减轻由非截短型多囊蛋白-1突变所致小鼠多囊肾病严重程度

XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice.
PubMed 文献 · J Am Soc Nephrol · 2022-10-21

研究构建模拟人类Pkd1 R2220W的低功能错义突变小鼠模型Pkd1 R2216W,发现活性XBP1可增加PC1 R2216W水平及纤毛转运,转基因表达剪接型XBP1可减少细胞增殖并改善多囊肾病进展,提示针对低功能突变治疗可能有效。

要点

  • 在培养细胞中,活性XBP1增加PC1 R2216W水平及纤毛转运。
  • Pkd1 R2216W纯合或与条件性Pkd1 fl反式杂合小鼠在新生或成年期失活后出现严重ADPKD。
  • 在将形成囊肿的肾小管节段转基因表达剪接型XBP1,可减少细胞增殖并改善Pkd进展的结构和功能参数。

核心结论

  • 通过XBP1活性调节内质网伴侣功能可改善PC1小鼠模型的多囊肾病,提示针对低功能突变的治疗靶向可能。

研究设计与样本

  • 基于人类低功能等位基因Pkd1 R2220W构建Pkd1 REJ结构域错义突变小鼠模型Pkd1 R2216W,并检测转基因激活XBP1对ADPKD进展的影响。

主要发现

  • 在携带PC1 R2216W突变的培养细胞中,活性XBP1表达增加PC1 R2216W水平及纤毛转运。
  • Pkd1 R2216W纯合小鼠或Pkd1 R2216W与条件性Pkd1 fl等位基因反式杂合小鼠在新生期或成年期失活后出现严重ADPKD。
  • 在将形成囊肿的肾小管节段转基因表达剪接型XBP1,可减少细胞增殖,并根据结构和功能参数改善Pkd进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in Pkd1 and Pkd2. They encode the polytopic integral membrane proteins polycystin-1 (PC1) and polycystin-2 (PC2), respectively, which are expressed on primary cilia. Formation of kidney cysts in ADPKD starts when a somatic second hit mechanism inactivates the wild-type Pkd allele. Approximately one quarter of families with ADPDK due to Pkd1 have germline nonsynonymous amino acid substitution (missense) mutations. A subset of these mutations is hypomorphic, retaining some residual PC1 function. Previous studies have shown that the highly conserved Ire1 α -XBP1 pathway of the unfolded protein response can modulate levels of functional PC1 in the presence of mutations in genes required for post-translational maturation of integral membrane proteins. We examine how activity of the endoplasmic reticulum chaperone-inducing transcription factor XBP1 affects ADPKD in a murine model with missense Pkd1 . METHODS: We engineered a Pkd1 REJ domain missense murine model, Pkd1 R2216W , on the basis of the orthologous human hypomorphic allele Pkd1 R2220W , and examined the effects of transgenic activation of XBP1 on ADPKD progression. RESULTS: Expression of active XBP1 in cultured cells bearing PC1 R2216W mutations increased levels and ciliary trafficking of PC1 R2216W . Mice homozygous for Pkd1 R2216W or heterozygous for Pkd1 R2216Win trans with a conditional Pkd1 fl allele exhibit severe ADPKD following inactivation in neonates or adults. Transgenic expression of spliced XBP1 in tubule segments destined to form cysts reduced cell proliferation and improved Pkd progression, according to structural and functional parameters. CONCLUSIONS: Modulating ER chaperone function through XBP1 activity improved Pkd in a murine model of PC1, suggesting therapeutic targeting of hypomorphic mutations.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Krappitz M, Bhardwaj R, Dong K, et al. XBP1 Activation Reduces Severity of Polycystic Kidney Disease due to a Nontruncating Polycystin-1 Mutation in Mice. J Am Soc Nephrol. 2022. PMID: 36270750. doi:10.1681/ASN.2021091180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。